Check out your Company Bowl for anonymous work chats.
Tackling health equity challenges was a featured discussion topic at the Fierce Healthcare Payer Summit this week. Our Chief Clinical Officer and Head of Health Equity Vindell Washington shared strategies and principles we’re applying to Verily solutions: ▶ Design for health equity from the beginning. It’s hard to retrofit. ▶ When it comes to bias and AI, be thoughtful about what data you're using to train the model. ▶ To close health disparities we need to innovate and design with the communities we serve.
Genomic data is generated from millions of individuals worldwide, offering opportunities to drive research and improve clinical care. Sharing this data is critical to advancing discovery in precision medicine. Collectively, we can and should do more to enable genomic data sharing. Here are 12 recommended actions that can be done now, detailed in a newly published Nature Portfolio paper: https://lnkd.in/gSWSS3CV Authors of the publication, including Verily Workbench CTO David Glazer, examined the genomic data sharing landscape, identifying current best practices and future opportunities to turn data into discovery. “Millions of people choose to donate their health-related data to help others. We in the research community can honor their choice by supporting wide data sharing to fuel as many discoveries as possible and wise data sharing to ensure data is used as intended. - David Glazer
Recently, we dropped the first episode of our new #VerilyNof1 documentary series, bringing to life the promise of precision health through wastewater-based epidemiology. Set in Las Vegas, this is a story of a new innovation to help detect the presence of infectious disease in a population that changes daily. Episode 2 in the series is coming soon!
Not only does wastewater monitoring help public health officials understand what infectious diseases might be present in a community, but it is also population equitable. If you are part of the 80% of the U.S. population contributing to a sewer shed, you are counted. Fierce Healthcare breaks down Verily’s approach to wastewater monitoring and our recent activation at HLTH USA 2024.
We are thrilled to receive the “Building Tomorrow Together” award from the Dallas Regional Chamber for our commitment to fostering healthcare innovation and collaboration in the Dallas area. The Verily leadership team is pictured here with our Chairman and CEO Stephen Gillett holding the award. Earlier this year, we announced the Verily Dallas office as our new headquarters. We are excited to further contribute to this growing healthcare and tech community.
Heard at HLTH USA! MedCity News sat down with Vindell Washington, our Chief Clinical Officer and Head of Health Equity, to talk about our chronic care solution Verily Lightpath,* and how data and technology can be leveraged to deliver more personalized, precise and equitable care. *To be available in early 2026
Hear Verily’s Chief People Officer Kerrie Peraino talk to Jaime Klein of Inspire Human Resources about her insights on human-centric leadership, the opportunities for AI in HR, and how companies like Verily are developing their leaders.
Recently, at HLTH USA and in the surrounding Las Vegas area, Verily, the Southern Nevada Health District and Clark County Water Reclamation District, monitored certain infectious disease pathogens in the community wastewater. The insights will help inform the public health response to infectious disease in a city that sees so many new visitors during a major event. Wastewater epidemiology is transforming how we detect and respond to the spread of viruses. Get the basics – how it was born, what wastewater is, and the work Verily scientists are doing to successfully track a variety of infectious diseases.
Traditional public health monitoring for infectious diseases often takes days to weeks. Verily partners with treatment facilities to bring wastewater epidemiology to the entertainment capital of the world, Las Vegas, Nevada, for near real time detection of pathogens — helping to keep the community informed.
As part of several policy updates finalized in August 2024, the Centers for Medicare & Medicaid Services endorsed the concept of “fit-for-purpose” (FFP) studies and announced plans to issue a FFP study guidance document. To help inform this forthcoming guidance and contribute to ongoing dialogue around the role of FFP studies in the context of coverage with evidence development for emerging medical technologies, experts, including Verily’s Caroline Marra, provide a framework for FFP study design and data source selection. The work is published in two parts in Health Affairs Forefront.
